EUROPEAN TRAINING CENTRES

Würzburg

 

 
Bayerische-Julius-Maximilans University,
Department of Medicine, Division of Nephrology
Würzburg, Germany

 

 

 

Peer Reviewed Publications in International Journals (only English) 2000-2002


Publication List: Peer review publications starting January 2000 to the present (November 2002)


Heinloth A, Heermeier K, Raff U, Wanner C, Galle J. Stimulation of Nicotinamide Adenine Dinucleotide Phosphate oxidase by oxidized Low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Nephrol 2000;11:1819-1825.

Bolz SS, Galle J, Derwand R, De Wit C, and Pohl U. Oxidized LDL increase the sensitivity of the contractile apparatus in isolated resistance arteries for Ca2+ via a Rho- and Rho-kinase-dependent mechanism. Circulation 102:2402-2410, 2000.

Galle J, Lehmann-Bodem C, Hübner U, Heinloth A, Wanner C. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O2- formation. Nephrol Dial Transplant 2000;15:339-346.

Lopau K, Kleinert D, Erler J, Schramm L, Heidbreder E, Wanner C. Tacrolimus in acute renal failure: does L-arginine-infusion prevent changes in renal hemodynamics? Transplant Int 2000;13:436-442.

Sohn H Y, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J and Pohl U. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. British Journal of Pharmacology 2000;131;667-672.

Heermeier K, Leicht W, Palmetshofer A, Ullrich M, Wanner C, Galle J. Oxidized LDL suppresses NF-kB and overcomes protection from apoptosis in activated endothelial cells. J Am Soc Nephrol 2001;12:456-463

Lopau K, Hefner L, Bender G, Heidbreder E, Wanner C. Haemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury. Nephrol Dial Transplant 2001;16:1592-1597

Quaschning T, Ruschitzka FT, Shaw S, Lüscher TF; Aldosterone receptor antagonism normalizes vascular function in11b hydroxysteroid dehydrogenase deficient hypertension. Hypertension 2001;37:801-805

Quaschning T, d'Uscio LV, Shaw S, Lüscher TF; Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension. Hypertension 2001;37:1008-1113

Quaschning T, d'Uscio LV, Shaw S, Viswambharan H, Ruschitzka FT, Lüscher TF; Chronic vasopeptidase inhibition restores endothelin converting enzyme activity and endothelin levels in salt-sensitive hypertension. Nephrol Dial Transplant 2001;16:1176-1182

Quaschning T, Ruschitzka FT, Noll G, de Gottardi A, Rossier M, Enseleit F, Lüscher TF, Shaw S; ET-A receptor antagonism prevents vascular dysfunction in 11ß-hydroxysteroiddehydrogenase deficient hypertension. Role of Nitric Oxide. Circulation 2001;103:3129-3135

Schwedler S, Schinzel R, Metzger T, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002;62:301-310

Schramm L, La M, Heidbreder E, Hecker M, Beckman JS, Lopau K, Zimmermann J, Rendl J, Reiners C, Winderl S, Wanner C, Schmidt HHHW. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int 2002;61:1423-1432

Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage. Kidney Int 2002;62:1791-1798

Hoffmann K, CK Dreger, AL Olins, DE Olins, LD Shultz, BL Karl, R Kaps, D Müller, A Vayá, J Aznar, RE Ware, NS Cruz, TH Lindner, H Herrmann, A Reis, K Sperling. Mutations in the gene encoding the lamin B receptor produce an alterednuclear morphology in granulocytes (Pelger-Huët anomaly). Nature genetics 2002; 31, 410-414.

Ibarra C, Galle J, Melichar VO, Mameghani A, Smolenski A, Walter U, Schmidt HHHW. Phosphorylation of blood vessel VASP at serine 239 as in vivo marker of endothelial function. Mol Pharmacol 2002;61:312-319

Heinloth A., Fischer B, Brüne B, Galle J. Nitric Oxide prevents oxidized LDL-induced, p53 dependent apoptosis in macrophages via guanylate cyclase stimulation. Atherosclerosis 2002;162:93-101

Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation ? Kidney Int 2002 (in press)

Quaschning T, Ruschitzka FT, Shaw S, Morawietz H, Goettsch W, Lüscher TF, Gassmann M, Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
FASEB Journal 2002 (in press)

Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, Holtz J: Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1. Clin Sci 2002 (in press)

Quaschning T, Kocak S, Wanner C, Bauer C, Neumayer H-H, Galle J, Hocher B: Nitric Oxide dependent Regulation of Endothelial Function in Endothelin transgenic mice. Nephrol Dial Transplant 2002 (in press)

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Cardiovascular mortality in dialysis patiens. Low Ahsg/Fetuin serum levels may be a critical factor. 2002 (in revision)

Schwedler S, Guderian F, Dämmrich J, Wanner C. Tubular staining of modified C-reactive protein correlates with severity of diabetic nephropathy. 2002 (submitted)

Naujoks H, Kungys B. Wanner C. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis. 2002 (submitted)

Heinloth A, Schuerle D, Baumeister E, Bartrow M, Wolf G, Galle J: Oxidized LDL modulates p27kip1 expression and cell cycle progression in human endothelial cells. 2002 (submitted)

Schneider R, Raff U, Vornberger N, Freund R, Schramm L, Schmidt HHHW, Galle J: Ischemic acute renal failure: beneficial effects of L-Arginin substitution on kidney function. 2002 (submitted)

Raff U, Schneider R, Gassel AM, Vornberger N, Reber M, Freund R, Galle J: Impact of L-arginin on cell death and proliferation in ischemia/reperfusion injury in acute renal failure. 2002 (submitted)

Galle, J, Mameghani, A, Bolz, S.-S, Görg, M, Quaschning, T, Raff U, Barth, H, Wanner, C, and Pohl, U: OxLDL and its Compound LPC Potentiate AngII-induced Vasoconstriction by Stimulation of RhoA. 2002 (submitted)

Seibold S, Rudroff C, Weber M, Galle J, Wanner C, Marx M. Identification of a new tumor suppressor gene located at 8p21. 2002 (submitted)